Escola Bahiana de Medicina e Saúde Pública, Hospital São Rafael, Hospital Português, Salvador, BA - Brazil.
Arq Bras Cardiol. 2012 Sep;99(3):818-24. doi: 10.1590/s0066-782x2012005000080. Epub 2012 Aug 30.
The accuracy of the GRACE and TIMI scores in predicting coronary disease extension in patients with non-ST-elevation acute coronary syndromes (ACS) has not been established.
To assess the hypothesis that the GRACE and TIMI risk scores satisfactorily predict coronary disease extension in patients withnon-ST-elevation ACS undergoing coronary angiography.
Individuals meeting the objective criteria for ACS and undergoing coronary angiography during hospitalization were consecutively assessed. Angiographic coronary disease was described as follows: quantification of coronary disease extension by using Gensini score; presence of any coronary artery obstruction (> 70% or > 50% when affecting left main coronary artery); and presence of severe disease (three-vessel disease or affecting the left main coronary artery).
Of 112 patients assessed, a positive correlation of the Gensini score was observed with the GRACE (p = 0.017) and TIMI (p = 0.02) scores, but that association was weak (r = 0.23 and r = 0.27; respectively). The GRACE score could predict neither obstructive coronary disease (area under the ROC curve = 0.57; 95% CI = 0.46 - 0.69), nor severe coronary disease (ROC = 0.59; 95% CI = 0.48 - 0.70). The TIMI score proved to be a modest predictor of coronary disease (ROC = 0.65; 95% CI = 0.55 - 0.76) and of severe coronary disease (ROC = 0.66; 95% CI = 0.56 - 0.76).
(1) There is a positive association between the values of the TIMI or GRACE scores and the extension of coronary artery disease in patients with ACS; (2) however, the degree of that association is not sufficient to make those scores accurate predictors of coronary angiography results.
GRACE 和 TIMI 评分在预测非 ST 段抬高型急性冠状动脉综合征(ACS)患者冠状动脉疾病进展的准确性尚未确定。
评估以下假设,即 GRACE 和 TIMI 风险评分能够令人满意地预测接受冠状动脉造影的非 ST 段抬高型 ACS 患者的冠状动脉疾病进展。
连续评估符合 ACS 客观标准并在住院期间接受冠状动脉造影的个体。冠状动脉疾病的血管造影描述如下:使用 Gensini 评分定量冠状动脉疾病进展;任何冠状动脉阻塞的存在(影响左主干冠状动脉时 > 70%或 > 50%);以及严重疾病的存在(三血管疾病或影响左主干冠状动脉)。
在评估的 112 例患者中,Gensini 评分与 GRACE(p = 0.017)和 TIMI(p = 0.02)评分呈正相关,但相关性较弱(r = 0.23 和 r = 0.27;分别)。GRACE 评分既不能预测阻塞性冠状动脉疾病(ROC 曲线下面积 = 0.57;95%CI = 0.46-0.69),也不能预测严重冠状动脉疾病(ROC = 0.59;95%CI = 0.48-0.70)。TIMI 评分被证明是冠状动脉疾病(ROC = 0.65;95%CI = 0.55-0.76)和严重冠状动脉疾病(ROC = 0.66;95%CI = 0.56-0.76)的适度预测因子。
(1)ACS 患者 TIMI 或 GRACE 评分值与冠状动脉疾病进展之间存在正相关;(2)然而,这种关联的程度不足以使这些评分成为冠状动脉造影结果的准确预测因子。